Abstract
The 2010 HIV Diagnostics Conference brought together approximately 260 representatives from public health laboratories, test manufacturers and federal agencies for a series of test method and technology presentations, as well as policy discussions related to HIV screening in the USA. The meeting was particularly substantive in the context of moving toward a consensus laboratory testing algorithm that capitalizes on the improved sensitivities and turnaround times associated with newer technologies. This article provides a brief overview of several meeting topics, including point-of-care testing algorithms, fourth-generation immunoassays, recency testing and new technologies.
Acknowledgements
The author is grateful to Mark W Pandori of the San Francisco Department of Public Health Laboratory for helpful discussions.
Financial & competing interests disclosure
The author is an employee of mBio Diagnostics, Inc. (discussed in the ‘New technologies’ section) and was a presenter at the 2010 conference. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.